Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3, Supplement 1 , Pages S9-S14 , March 2008

Congenital and Acquired Brain Injury. 2. Medical Rehabilitation in Acute and Subacute Settings

  • Steven R. Flanagan, MD

      Affiliations

    • Mount Sinai Hospital, New York, NY
    • Corresponding Author InformationCorrespondence to Steven R. Flanagan, MD, Mt Sinai Hospital, Box 1240B, 1 Gustave L. Levy Pl., New York, NY 10029-6504
    • ,
  • Christina Kwasnica, MD

      Affiliations

    • Barrow Neurologic Institute, Phoenix, AZ
    • ,
  • Allen W. Brown, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN
    • ,
  • Elie P. Elovic, MD

      Affiliations

    • Kessler Medical Rehabilitation Research and Education Center, West Orange, NJ
    • ,
  • Sunil Kothari, MD

      Affiliations

    • The Institute for Rehabilitation and Research, Houston, TX.

References 

  1. Sandel ME, Mysiw WJ. The agitated brain injured patient (Part 1: definitions, differential diagnosis, and assessment). Arch Phys Med Rehabil. 1996;77:617–623
  2. Management of the agitated intensive care unit patient. Crit Care Med. 2002;30:S97–S123
  3. Silver JM, Yudofsky SC, Anderson KE. Aggressive disorders. In:  Yudofsky SC,  Silver JM,  McAllister TW editor. Textbook of traumatic brain injury. Washington (DC): American Psychiatric Publishing; 2004;p. 259–277
  4. Liu LL, Gropper MA. Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection. Drugs. 2003;63:755–767
  5. Jacobi J, Fraser GL, Coursin DB, et al. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM) American Society of Health-System Pharmacists (ASHP) American College of Chest Physicians Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119–141
  6. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855–857
  7. Goldstein LB. Common drugs may influence motor recovery after stroke (The Sygen In Acute Stroke Study Investigators). Neurology. 1995;45:865–871
  8. Rao N, Jellinek HM, Woolston DC. Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil. 1985;66:30–34
  9. Lombard LA, Zafonte RD. Agitation after traumatic brain injury: considerations and treatment options. Am J Phys Med Rehabil. 2005;84:797–812
  10. Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2003;(1):CD003299.
  11. Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD. Dysautonomia after traumatic brain injury: a forgotten syndrome?. J Neurol Neurosurg Psychiatry. 1999;67:39–43
  12. Baguley IJ, Cameron ID, Green AM, Slewa-Younan S, Marosszcky JE, Gurka JA. Pharmacological management of dysautonomia following traumatic brain injury. Brain Inj. 2004;18:409–417
  13. Bullard DE. Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol. 1987;21:609–611
  14. Cuny E, Richer E, Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal baclofen therapy. Brain Inj. 2001;15:917–925
  15. Zafonte R, Elovic EP, Lombard L. Acute care management of post-TBI spasticity. J Head Trauma Rehabil. 2004;19:89–100

    ⁎

  16. Meythaler JM, Clayton W, Davis LK, Guin-Renfroe S, Brunner RC. Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil. 2004;19:101–108
  17. Mayer NH. Choosing upper limb muscles for focal intervention after traumatic brain injury. J Head Trauma Rehabil. 2004;19:119–142
  18. Yablon SA, Agana BT, Ivanhoe CD, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open labeled trial. Neurology. 1996;47:939–944
  19. Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience [published erratum in: Arch Phys Med Rehabil 1999;80:474]. Arch Phys Med Rehabil. 1999;80:13–19
  20. Hsieh JC, Penn RD. Intrathecal baclofen in the treatment of adult spasticity. Neurosurg Focus. 2006;21:e5
  21. Elovic E, Zafonte RD. Spasticity management in traumatic brain injury. Phys Med Rehabil State Art Rev. 2001;15:327–348

    ⁎

  22. Fakhry SM, Trask AL, Waller MA, Watts DD IRTC Neurotrauma Task Force. Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges. J Trauma. 2004;56:492–500

    ⁎

  23. Wagner AK, Fabio T, Zafonte RD, Goldberg G, Marion DW, Peitzman AB. Physical medicine and rehabilitation consultation: relationships with acute functional outcome, length of stay, and discharge planning after traumatic brain injury. Am J Phys Med Rehabil. 2003;82:526–536

    ⁎

  24. CMS. Medicare Program. Inpatient rehabilitation facility prospective payment system for federal fiscal year 2007; Proposed Rule. 71 Federal Register 2006 (28106).
  25. Medicare Payment Advisory Commission. Report to the Congress: Medicare payment policy. In: Washington (DC): MedPAC; 2006;p. 225–241Available at: http://www.medpac.gov/documents/Mar06_EntireReport.pdf. Accessed December 11, 2007.
  26. Paddock SM, Escarce JJ, Hayden O, Buntin MB. Did the Medicare inpatient rehabilitation facility prospective payment system result in changes in relative patient severity and relative resource use?. Med Care. 2007;45:123–130
  27. World Health Organization. International classification of functioning, disability and health. Geneva: WHO; 2001;

    ⁎

  28. Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop Relat Res. 1991;13–29Feb(263)
  29. Naraghi FF, DeCoster TA, Moneim MS, Miller RA, Rivero D. Heterotopic ossification. Orthopedics. 1996;19:145–151
  30. Ippolito E, Formisano R, Caterini R, Farsetti P, Penta F. Operative treatment of heterotopic hip ossification in patients with coma after brain injury. Clin Orthop Rel Res. 1999;130–138Aug(365)
  31. McAuliffe JA, Wolfson AH. Early excision of heterotopic ossification about the elbow followed by radiation therapy. J Bone Joint Surg Am. 1997;79:749–755
  32. Spielman G, Gennarelli TA, Rogers CR. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil. 1983;64:539–542
  33. Garland DE. Surgical approaches for resection of heterotopic ossification in traumatic brain-injured adults. Clin Orthop Relat Res. 1991;5–70Feb(263)
  34. Yablon SA, Rock WA, Nick TG, Sherer M, McGrath CM, Goodson KH. Deep vein thrombosis: prevalence and risk factors in rehabilitation admission with brain injury. Neurology. 2004;63:485–491
  35. Cifu DX, Kaelin DL, Wall BE. Deep venous thrombosis: incidence on admission to a brain injury rehabilitation program. Arch Phys Med Rehabil. 1996;77:1182–1185
  36. Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004;28:807–811
  37. Wen PY, Schiff D, Kesari S, Drappatz J, Gigas DL, Doherty L. Medical management of patients with brain tumors. J Neurooncol. 2006;80:313–332
  38. Rogers F, Rebuck JA, Sing RF. Venous thromboembolism in trauma: an update for the intensive care unit practitioner. J Intensive Care Med. 2007;22:26–37
  39. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):388S–400S

    ⁎

  40. Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53:38–42
  41. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000;160:2327–2332
  42. Meythaler JM, DeVivo MJ, Hayne JB. Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation. Arch Phys Med Rehabil. 1996;77:1–5
  43. Meythaler JM, Fisher WS, Rue LW, Johnson A, Davis L, Brunner RC. Screening for venous thromboembolism in traumatic brain injury: limitations of D-dimer assay. Arch Phys Med Rehabil. 2003;84:285–290
  44. Mysiw WJ, Fugate LP, Clinchot DM. Assessment, early rehabilitation intervention, and tertiary prevention. In:  Zasler ND,  Katz DI,  Zafonte RD editor. Brain injury medicine: principles and practice. New York: Demos; 2007;p. 283–301
  45. Ghigo E, Masel B, Aimaretti G, Leon-Carrion J, et al. Consensus guideline on screening for hypopituitarism following traumatic brain injury. Brain Inj. 2005;19:711–724

    ⁎

  46. Chong D, Hirsch L. Which EEG patterns warrant treatment in the critically ill?. J Clin Neurophysiol. 2005;22:79–91

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

 Reprints are not available from the author.

PII: S0003-9993(07)01858-8

doi: 10.1016/j.apmr.2007.12.010

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3, Supplement 1 , Pages S9-S14 , March 2008

Article Tools